Hyperparathyroidism.

Area of Science:

• Endocrinology
• Nephrology
• Metabolic Bone Disease

Background:

• Hyperparathyroidism stems from increased parathyroid hormone activity.
• Primary hyperparathyroidism is common, especially in postmenopausal women.
• Secondary hyperparathyroidism is often linked to vitamin D deficiency or chronic kidney disease.

Purpose of the Study:

• To review the causes and management of primary and secondary hyperparathyroidism.
• To highlight current and emerging treatment strategies.
• To discuss the complexities of vitamin D deficiency and its role.

Main Methods:

• Literature review of hyperparathyroidism causes, diagnosis, and treatments.
• Analysis of current medical and surgical management options.
• Discussion of challenges in defining and treating vitamin D deficiency.

Main Results:

• Primary hyperparathyroidism is treatable with surgery (parathyroidectomy) or medical therapies (bisphosphonates, hormone replacement, calcimimetics).
• Vitamin D deficiency is a frequent cause of secondary hyperparathyroidism, particularly in the elderly.
• Secondary hyperparathyroidism in chronic kidney disease contributes to renal bone disease, with new treatments emerging.

Conclusions:

• Hyperparathyroidism management varies based on type and severity.
• Minimally invasive surgery is increasingly used for primary hyperparathyroidism.
• Further research is needed for optimal vitamin D deficiency management and addressing renal bone disease in CKD.